Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
ClinicalTrials.gov study NCT01541644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatme
ClinicalTrials.gov study NCT05137054. IPD Sharing: YES. Countries: 5. Publications: 0.
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
ClinicalTrials.gov study NCT05191472. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
ClinicalTrials.gov study NCT00793650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01085214. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02506959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02075021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03202628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
ClinicalTrials.gov study NCT03622775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
ClinicalTrials.gov study NCT05556798. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT05288062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT02043860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
ClinicalTrials.gov study NCT02353468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
ClinicalTrials.gov study NCT01146834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00966693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01729338. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05495620. IPD Sharing: NO. Countries: 0. Publications: 1.
A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)
ClinicalTrials.gov study NCT04135963. IPD Sharing: YES. Countries: 1. Publications: 0.
Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant
ClinicalTrials.gov study NCT01706666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01729091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.